Category:
Active Pharmaceutical Ingredients
CAS NO:
1146702-54-6
Standard:
In-house Standards,
Oncology Blood Cancer
Idelalisib (CAL-101) is a potent, selective oral inhibitor of the delta isoform of PI3K. It features the molecular formula C24H28ClN5O and CAS No. 976655-20-6. The compound is synthesized via advanced organic coupling processes for pharmaceutical-grade purity.
Strictly monitor for hepatotoxicity and immune-mediated adverse events. Store under inert atmosphere at 2-8°C to maintain stability and prevent hydrolysis.